BioSpace News Archive

FORCE Communications announced the creation of a visual depiction of the SARS-CoV-2 life cycle, which describes opportunities for the development of drugs and vaccines to treat and prevent coronavirus disease 2019 (COVID-19)

High concentration nitric oxide (150 ppm) is statistically significant compared to both low concentration nitric oxide (85 ppm) and control arms on both the primary endpoint and the key secondary endpoint

Texas Children’s Hospital announces it will build a freestanding hospital in Austin to meet Central Texas families’ needs

Progenabiome is starting two FDA-approved clinical trials that include hydroxychloroquine.

Trading under ASRT on Nasdaq Global Select Market Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million¹ Upwards of $40 million in Expected Cost Synergies [20-May-2020] LAKE FOREST, Ill. , May 20, 2020 /PRNewswire/ -- Assertio Holdings, Inc., the successor issuer to Assertio Therapeutics, Inc. , (“Assertio” ) (NASDAQ: ASR

Building on its earlier reveal at the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG) today launched its Targeted Gene Expression Solution for single cell and shortly following for spatial genomic research.

OpSens Inc. reached an important milestone with more than 100,000 patients evaluated with the OptoWire™, a pressure guidewire for the diagnosis and treatment of coronary artery stenosis.

25-year Healthcare Veteran Takes the Reins as Company Sales Projected to Expand during the Current Fiscal Year G. Darcy Klug to Remain as Chairman and CFO [20-May-2020] LAFAYETTE, Louisiana , May 20, 2020 /PRNewswire/ -- RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company primarily engaged in the sales and distrib

- Data supports pharmacokinetic and safety profile for Neurelis’ lead product, VALTOCO® (diazepam nasal spray), the first and only nasal spray treatment for seizure cluster rescue in pediatric patients 6 years of age and older, adolescents, and adults - Data also further highlights the permeation enhancer potency of Intravail® for both small and large molecules; Intravail is a key component of VALTOCO formulation [20-May-2020]

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO s